These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20853605)
21. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study. Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827 [TBL] [Abstract][Full Text] [Related]
22. [Hereditary and acquired iron overload]. de Korwin JD Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275 [TBL] [Abstract][Full Text] [Related]
23. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Zanella A; Bianchi P; Iurlo A; Boschetti C; Taioli E; Vercellati C; Zappa M; Fermo E; Tavazzi D; Sampietro M Blood Cells Mol Dis; 2001; 27(3):653-61. PubMed ID: 11482880 [TBL] [Abstract][Full Text] [Related]
24. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease]. Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191 [TBL] [Abstract][Full Text] [Related]
25. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375 [TBL] [Abstract][Full Text] [Related]
26. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of transfusion hemochromatosis prevalence, SFVTT-01 study: preliminary results of the SFVTT working group]. Leo-Kodeli S; Renaudier P; Lassale B Transfus Clin Biol; 2014 Nov; 21(4-5):182-8. PubMed ID: 25277422 [TBL] [Abstract][Full Text] [Related]
28. Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes. Mariani R; Pelucchi S; Arosio C; Coletti S; Pozzi M; Paolini V; Trombini P; Piperno A Blood Cells Mol Dis; 2010 Mar; 44(3):159-63. PubMed ID: 20117027 [TBL] [Abstract][Full Text] [Related]
29. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198 [TBL] [Abstract][Full Text] [Related]
30. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952 [TBL] [Abstract][Full Text] [Related]
31. Hereditary hemochromatosis in north-eastern Romania. Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455 [TBL] [Abstract][Full Text] [Related]
32. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835 [TBL] [Abstract][Full Text] [Related]
33. Relation between HFE mutations and mild iron-overload expression. Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847 [TBL] [Abstract][Full Text] [Related]
34. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. Nassar BA; Zayed EM; Title LM; O'Neill BJ; Bata IR; Kirkland SA; Dunn J; Dempsey GI; Tan MH; Johnstone DE Can J Cardiol; 1998 Feb; 14(2):215-20. PubMed ID: 9520858 [TBL] [Abstract][Full Text] [Related]
35. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients. Politou M; Kalotychou V; Pissia M; Rombos Y; Sakellaropoulos N; Papanikolaou G Haematologica; 2004 Apr; 89(4):490-2. PubMed ID: 15075083 [TBL] [Abstract][Full Text] [Related]
36. Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia. Zhang X; Shi Y; Huang Y; Zhang G; He Y; Jiang E; Wei J; Yang D; Ma Q; Zhang R; Zhai W; Feng S; Han M Hematology; 2018 Jun; 23(5):291-298. PubMed ID: 29046127 [TBL] [Abstract][Full Text] [Related]
37. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358 [TBL] [Abstract][Full Text] [Related]
38. The influence of hemochromatosis mutations on iron overload of thalassemia major. Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452 [TBL] [Abstract][Full Text] [Related]
39. Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia. Lee SE; Yahng SA; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW Acta Haematol; 2013; 129(2):72-7. PubMed ID: 23154600 [TBL] [Abstract][Full Text] [Related]
40. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]